InforMedix Holdings, Inc. (OTCBB:IFMX) today announced plans to offer the Med-eMonitor System, developed and patented by InforMedix, to selected University of Pennsylvania (Penn) employees and retirees with chronic health care conditions known to cause high rates of stroke, heart disease, premature death, and reduced quality-of-life.